• Home
  • About Journal
    Journal Introduction
    Editorial Board
    Youth Editorial Board
    Cooperating Institutions
    Editorial Department
  • Submission Guidelines
  • Policies & Statements
    Ethical Guidelines for Publication
    Academic Misconduct Statement
    Open Access (OA) Statement
    AIGC Use Statement
  • Journal Subscription
  • Download Center
  • 中文版
Cite this article:
WANG Chong,LIU Wen,ZHU Jiong,HU Zengyao.Analysis and suggestions of national drug quality disclosure under the new situation[J].Journal Of Pharmaceutical Research,2023,42(3):211-213,216[Click to copy]
【Print this page】      【Download PDF Full Text】   【View/Add Comment】  【Download reader】  【 Close 】
←Previous|Next→ Archive    Advanced Search
This article has been viewed: 2486times   Download 2494次 QR Code for this article
Scan with your phone!
新形势下国家药品质量通告态势分析与建议
王翀1,刘文1,朱炯1,胡增峣2
Font:Larger+|Default|Smaller-
(1.中国食品药品检定研究院,北京 102629;2.国家药品监督管理局,北京 100037)
摘要:
国家药品质量通告是国家药监局依法依规主动公开药品质量状况的重要载体。在新媒体飞速发展和新版《药品管理法》加大假劣药品处罚力度等时代背景下,国家药品质量通告如何更好发挥作用也面临着诸多有利和不利因素。本文利用态势分析法从优势、劣势、机遇、挑战4个方面进行分析,探索国家药品质量通告在新形势下应关注的主要矛盾,并从服务监管、政策宣传、舆情监测、信用修复等多个方面为国家药品质量通告提出适应新形势的建议,以期为相关部门因势利导,扬长避短,精准施策提供参考。
关键词:  国家药品质量通告  态势分析法  信用修复  舆情监测
DOI:10.13506/j.cnki.jpr.2023.03.015
基金项目:
Analysis and suggestions of national drug quality disclosure under the new situation
WANG Chong1,LIU Wen1,ZHU Jiong1,HU Zengyao2
(1.National Institutes for Food and Drug Control,Beijing 102629, China;2.National Medical Products Administration, Beijing 100037, China)
Abstract:
National drug quality disclosure was an important way for the National Medical Products Administration to actively disclose the quality of drugs in accordance with laws and regulations. Against the backgrounds of the rapid development of new media, and the increased penalties for counterfeit and inferior drugs in the new version of the Drug Administration Law, the national drug quality disclosure was faced with many internal and external favorable and unfavorable factors. This paper analyzed strengths, weaknesses, opportunities, threats with the SWOT method, explored the main contradictions that the national drug quality disclosure should focus on under the new situation, and put forward suggestions from the aspects of strengthening drug supervision, policy publicity, public opinion monitoring, credit restoration, etc. for national drug quality disclosure to adapt to the new situation, in order to provide reference for relevant departments to make the best use of the situation, promote advantages and disadvantages, and implement precise policies.
Key words:  National drug quality Disclosure  SWOT  Credit repair  Public opinion monitoring
Today's Visits:511    Total Visits:2383242
Website copyright:Editorial Board of Journal of Pharmaceutical Research     鲁ICP备17018036号-3     鲁公网安备 37010202001351号
Sponsored by:Shandong Institute for Food and Drug Control Shandong Pharmaceutical Association Address:No.2749 Xinluo Street,High-Tech Zone,Jinan,P.R.China Postcode:250101
Telephone Number:0531-81216586 Email :yaoxueyanjiu@163.com;yaoxueyanjiu@126.com
Technical Support:Beijing Qinyun Technology Co., Ltd.